Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06397378 · ClinicalTrials.gov registry record · NA
Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
A NA study of N/A - Healthy Subjects, sponsored by Michigan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 1
- Study location
NCT06397378: Recruiting NA study of N/A - Healthy Subjects, sponsored by Michigan State University.
NCT06397378 is a NA study of N/A - Healthy Subjects that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 123 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06397378, a NA study of N/A - Healthy Subjects, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 1
- Study location
Study Summary
HPV vaccines offer hope against HPV-associated cancers for males and females; however, the rate of vaccination has not reached projected public health goals. This study will engage key stakeholders in the research process to co-design and pilot testing a video-based intervention addressing low HPV vaccination rates among college students The intervention and its approach have the potential to reduce health disparities in HPV-associated cancers in young adults via low-cost technology and timely intervention.
Primary Outcome
The investigators will assess participants' intention to receive HPV vaccines before and after watching HPV vaccine-related videos, t
Conditions Studied
Interventions
- OTHER short videos related to HPV and the HPV vaccine
- OTHER CDC HPV Fact Sheet
Study Locations (1)
Michigan
- Michigan State University - East Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2024-08-16 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06397378 shows while recruiting
NCT06397378 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with N/A - Healthy Subjects appearing as the primary indexed condition, and to 2 interventions - of which short videos related to HPV and the HPV vaccine is the first listed.
NCT06397378 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06397378 about?
NCT06397378 is a clinical study titled "Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion". HPV vaccines offer hope against HPV-associated cancers for males and females; however, the rate of vaccination has not reached projected public health goals. This study will engage key stakeholders in the research process to co-design and pilot testing a video-based intervention addressing low HPV v...
What is the current status of trial NCT06397378?
This trial is currently recruiting. It is a NA study. The enrollment target is 123 participants. The study started on 2024-08-16. Estimated completion is 2026-06-30.
What conditions does trial NCT06397378 study?
This clinical trial studies the following conditions: N/A - Healthy Subjects.
What interventions are being tested in trial NCT06397378?
The interventions under investigation include: short videos related to HPV and the HPV vaccine (OTHER), CDC HPV Fact Sheet (OTHER).
Who is sponsoring clinical trial NCT06397378?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06397378 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for N/A - Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06397378's enrollment target sits among peer trials
123 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI